Advertisement

Topics

A New Method of Combating MAPK Inhibitor-Resistant Melanoma

11:30 EST 8 Nov 2017 | OncoTherapy Network

Researchers have found that melanoma patients may benefit from a holiday from MAPK inhibitors while alternative therapies stave off emergence of resistant melanoma clones.

Original Article: A New Method of Combating MAPK Inhibitor-Resistant Melanoma

NEXT ARTICLE

More From BioPortfolio on "A New Method of Combating MAPK Inhibitor-Resistant Melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....